Ryan Rhodes - 01 Jan 2026 Form 3 Insider Report for EDAP TMS SA (EDAP)

Role
Chief Executive Officer, Director
Signature
/s/ Blandine Confort, as Attorney-in-Fact
Issuer symbol
EDAP
Transactions as of
01 Jan 2026
Net transactions value
$0
Form type
3
Filing time
14 Jan 2026, 16:05:30 UTC
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Rhodes Ryan Chief Executive Officer, Director 4410 EL CAMINO REAL, SUITE 150, LOS ALTOS, /s/ Blandine Confort, as Attorney-in-Fact 14 Jan 2026 0001710383

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding EDAP Common Stock 301,149 01 Jan 2026 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding EDAP Stock Options 01 Jan 2026 Common Stock 800,000 $6.57 Direct F2, F3
holding EDAP Stock Options 01 Jan 2026 Stock Options 200,000 $11.87 Direct F4, F5
holding EDAP Stock Options 01 Jan 2026 Stock Options 100,000 $8.03 Direct F6, F7
holding EDAP Stock Options 01 Jan 2026 Stock Options 500,000 $1.42 Direct F8, F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes restricted stock units ("RSUs") granted pursuant to the 2025 RSU (Free Share) Plan of the Company on June 20, 2025. Each RSU represents the right to receive one share of EDAP common stock, four-sixths of which will vest on the second anniversary of the date of grant and the remaining two-sixths will vest in two installments on December 20, 2027 and on June 20, 2028, respectively.
F2 The options, which were granted on June 11, 2021, became exercisable with respect to one-sixth of the options on the six-month anniversary of the date of grant and became exercisable on a monthly basis thereafter through the third anniversary of the date of grant with respect to the remaining options.
F3 The option exercise price reflected was converted from 5.59 euros to U.S. dollars based on an exchange rate of EUR 1 to USD 1.1750.
F4 The options, which were granted on May 2, 2023, became exercisable with respect to one-sixth of the options on the six-month anniversary of the date of grant and became exercisable or will become exercisable on a monthly basis thereafter through the third anniversary of the date of grant with respect to the remaining options.
F5 The option exercise price reflected was converted from 10.10 euros into U.S. dollars based on an exchange rate of EUR 1 to USD 1.1750.
F6 The options, which were granted on March 26, 2024, became exercisable with respect to one-sixth of the options on the six-month anniversary of the date of grant and became exercisable or will become exercisable on a monthly basis thereafter through the third anniversary of the date of grant with respect to the remaining options.
F7 The option exercise price reflected was converted from 6.83 euros to U.S. dollars based on an exchange rate of EUR 1 to USD 1.1750.
F8 The options, which were granted on April 15, 2025, became exercisable with respect to one-sixth of the options on the six-month anniversary of the date of grant and became exercisable or will become exercisable on a monthly basis thereafter through the third anniversary of the date of grant with respect to the remaining options.
F9 The option exercise price reflected was converted from 1.21 euros into U.S. dollars based on an exchange rate of EUR 1 to USD 1.1750.

Remarks:

Exhibit 24 - Power of Attorney